Literature DB >> 29485677

Sex differences in heart failure.

Evann Eisenberg1, Katherine E Di Palo2, Ileana L Piña3.   

Abstract

Heart failure (HF) numbers continue to grow in the United States and approximately 50% of patients living with HF are women. For the provider, it is critical to understand the role that gender plays in recognition, diagnosis, and management. The purpose of this literature review is to highlight the prevalence of heart failure in women and discuss gender variations in epidemiology, symptoms, pharmacology, and treatment as well as examine the representation of women in clinical trials.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Gender Differences; Heart Failure; Women

Mesh：

Year:  2018        PMID： 29485677      PMCID： PMC6489832          DOI： 10.1002/clc.22917

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN： 0160-9289            Impact factor:   2.882


  61 in total

1.  Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.

Authors:  Boriana G Jahns; Werner Stein; Denise Hilfiker-Kleiner; Burkert Pieske; Günter Emons
Journal:  Am J Obstet Gynecol       Date:  2008-10       Impact factor: 8.661

Review 2.  Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.

Authors:  Giuseppe M C Rosano; Basil Lewis; Stefan Agewall; Sven Wassmann; Cristiana Vitale; Harald Schmidt; Heinz Drexel; Atul Patak; Christian Torp-Pedersen; Keld Per Kjeldsen; Juan Tamargo
Journal:  Eur Heart J       Date:  2015-05-06       Impact factor: 29.983

3.  Long-term trends in the incidence of and survival with heart failure.

Authors:  Daniel Levy; Satish Kenchaiah; Martin G Larson; Emelia J Benjamin; Michelle J Kupka; Kalon K L Ho; Joanne M Murabito; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

Review 4.  Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases.

Authors:  Nicoline Jochmann; Karl Stangl; Edeltraut Garbe; Gert Baumann; Verena Stangl
Journal:  Eur Heart J       Date:  2005-07-04       Impact factor: 29.983

5.  Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease.

Authors:  Frans H Rutten; Maarten-Jan M Cramer; Diederick E Grobbee; Alfred P E Sachs; Johannes H Kirkels; Jan-Willem J Lammers; Arno W Hoes
Journal:  Eur Heart J       Date:  2005-04-28       Impact factor: 29.983

6.  Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction.

Authors:  Danilo Neglia; Claudio Michelassi; Maria Giovanna Trivieri; Gianmario Sambuceti; Assuero Giorgetti; Lorenza Pratali; Michela Gallopin; Piero Salvadori; Oreste Sorace; Clara Carpeggiani; Rosa Poddighe; Antonio L'Abbate; Oberdan Parodi
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

7.  Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.

Authors:  Robbert Zusterzeel; Erica S Spatz; Jeptha P Curtis; William E Sanders; Kimberly A Selzman; Ileana L Piña; Haikun Bao; Angelo Ponirakis; Paul D Varosy; Frederick A Masoudi; Daniel A Caños; David G Strauss
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-02-24

8.  Long-term trends in the incidence of heart failure after myocardial infarction.

Authors:  Raghava S Velagaleti; Michael J Pencina; Joanne M Murabito; Thomas J Wang; Nisha I Parikh; Ralph B D'Agostino; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Circulation       Date:  2008-10-27       Impact factor: 29.690

9.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

Authors:  Franco Cecchi; Iacopo Olivotto; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Paolo G Camici
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

10.  Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Authors:  J McMurray; J Ostergren; M Pfeffer; K Swedberg; C Granger; S Yusuf; P Held; E Michelson; B Olofsson
Journal:  Eur J Heart Fail       Date:  2003-06       Impact factor: 15.534
View more
  30 in total

1.  An expanded landscape of human long noncoding RNA.

Authors:  Shuai Jiang; Si-Jin Cheng; Li-Chen Ren; Qian Wang; Yu-Jian Kang; Yang Ding; Mei Hou; Xiao-Xu Yang; Yuan Lin; Nan Liang; Ge Gao
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

2.  Sex-specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.

Authors:  Norman C Wang; Ure Mezu-Chukwu; Evan C Adelstein; Andrew D Althouse; Michael S Sharbaugh; Sandeep K Jain; Alaa A Shalaby; Andrew H Voigt; Samir Saba
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-03-27       Impact factor: 1.468

Review 3.  Update on Management of Cardiovascular Diseases in Women.

Authors:  Fabiana Lucà; Maurizio Giuseppe Abrignani; Iris Parrini; Stefania Angela Di Fusco; Simona Giubilato; Carmelo Massimiliano Rao; Laura Piccioni; Laura Cipolletta; Bruno Passaretti; Francesco Giallauria; Angelo Leone; Giuseppina Maura Francese; Carmine Riccio; Sandro Gelsomino; Furio Colivicchi; Michele Massimo Gulizia
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

4.  Biological Sex and Its Impact on Clinical Characteristics in Patients Presenting with Myocarditis.

Authors:  Moritz Mirna; Lukas Schmutzler; Albert Topf; Uta C Hoppe; Michael Lichtenauer
Journal:  Med Princ Pract       Date:  2021-11-11       Impact factor: 1.927

Review 5.  The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women - Chapter 6: Sex- and Gender-Specific Diagnosis and Treatment.

Authors:  Monica Parry; Harriette G C Van Spall; Kerri-Anne Mullen; Sharon L Mulvagh; Christine Pacheco; Tracey J F Colella; Marie-Annick Clavel; Shahin Jaffer; Heather J A Foulds; Jasmine Grewal; Marsha Hardy; Jennifer A D Price; Anna L E Levinsson; Christine A Gonsalves; Colleen M Norris
Journal:  CJC Open       Date:  2022-04-19

Review 6.  Sex differences in heart failure.

Authors:  Evann Eisenberg; Katherine E Di Palo; Ileana L Piña
Journal:  Clin Cardiol       Date:  2018-02-27       Impact factor: 2.882

7.  Focusing Heart Failure Research on Myocardial Fibrosis to Prioritize Translation.

Authors:  Merry L Lindsey; Kristine Y Deleon-Pennell; Amy D Bradshaw; R Amanda C Larue; Daniel R Anderson; Geoffrey M Thiele; Catalin F Baicu; Jeffrey A Jones; Donald R Menick; Michael R Zile; Francis G Spinale
Journal:  J Card Fail       Date:  2020-05-21       Impact factor: 6.592

Review 8.  Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities.

Authors:  Mohammad Javad Hajipour; Mehdi Mehrani; Seyed Hesameddin Abbasi; Ahmad Amin; Seyed Ebrahim Kassaian; Jessica C Garbern; Giulio Caracciolo; Steven Zanganeh; Mitra Chitsazan; Haniyeh Aghaverdi; Seyed Mehdi Kamali Shahri; Aliakbar Ashkarran; Mohammad Raoufi; Holly Bauser-Heaton; Jianyi Zhang; Jochen D Muehlschlegel; Anna Moore; Richard T Lee; Joseph C Wu; Vahid Serpooshan; Morteza Mahmoudi
Journal:  Chem Rev       Date:  2019-09-06       Impact factor: 60.622

9.  Potentially harmful drug prescription in elderly patients with heart failure with reduced ejection fraction.

Authors:  Paulino A Alvarez; Yubo Gao; Saket Girotra; Amgad Mentias; Alexandros Briasoulis; Mary S Vaughan Sarrazin
Journal:  ESC Heart Fail       Date:  2020-05-17

10.  National trends in heart failure mortality in men and women, United Kingdom, 2000-2017.

Authors:  Clare J Taylor; José M Ordóñez-Mena; Nicholas R Jones; Andrea K Roalfe; Sarah Lay-Flurrie; Tom Marshall; F D Richard Hobbs
Journal:  Eur J Heart Fail       Date:  2020-09-23       Impact factor: 17.349
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.